The funded vaccine brand is Shingrix. This replaced the Zostavax brand in 2022. Zostavax is no longer being made.
The shingles vaccine is fully funded for people aged 65. You need two doses of Shingrix, given 6 months apart. As long as you are 65 when you receive your first dose, both doses will be funded.